Journal rankings · indicator year 2016
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2016
Immunology journal rankings 2016
90 ranked journals · Subfield in Immunology and Microbiology
Immunology has 90 ranked journals in 2016. Its median journal scores above the world average: OJR 1.05 against 1.00, down 0.01 on 2015. A journal needs OJR 1.45 to reach Q1. The top three are Immunity, Nature Immunology, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2016. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2013–2015, the window the 2016 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
90 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2015. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2013–2015, the window the 2016 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2013–2015 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2007 to 2016. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 6.68Q1 | 18.23 2.09 down from 2015 | 724 | 100% | $10,400 | ||
2Nature ImmunologyNature Portfolio · United States | 4.67Q1 | 12.53 0.60 up from 2015 | 752 | 42% | $12,690 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 4.07Q1 | 10.16 1.76 down from 2015 | 709 | 95% | — | ||
4Seminars in ImmunologyElsevier BV · United States | 3.80Q1 | 10.52 0.36 up from 2015 | 172 | 46% | $4,370 | ||
5Journal of AutoimmunityElsevier BV · United Kingdom | 3.40Q1 | 9.27 0.31 down from 2015 | 320 | 42% | $5,420 | ||
6Annual Review of ImmunologyAnnual Reviews · United States | 3.10Q1 | 35.31 3.31 down from 2015 | 68 | 52% | — | ||
7Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 3.09Q1 | 8.68 0.16 down from 2015 | 1,610 | 66% | $4,900 | ||
8Nature reviews. ImmunologyNature Portfolio · United Kingdom | 2.95Q1 | 16.76 1.77 up from 2015 | 557 | 18% | — | ||
9Journal of Innate ImmunityOAKarger Publishers · Switzerland | 2.87Q1 | 3.44 5.80 down from 2015 | 217 | 100% | $3,590 | ||
10Seminars in ImmunopathologySpringer Science+Business Media · Germany | 2.67Q1 | 5.63 0.91 down from 2015 | 175 | 55% | $3,790 | ||
11Mucosal ImmunologyOAElsevier BV · United States | 2.60Q1 | 6.28 0.10 up from 2015 | 382 | 100% | $4,370 | ||
12Current Protocols in ImmunologyWiley · United States | 2.33Q1 | 8.03 4.56 up from 2015 | 48 | 18% | $5,050 | ||
13Clinical & Translational ImmunologyOAWiley · Australia | 2.22Q1 | 5.26 0.22 down from 2015 | 52 | 100% | $3,070 | ||
14Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 2.18Q1 | 5.40 0.06 up from 2015 | 176 | 16% | $5,490 | ||
15The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.89Q1 | 5.29 0.34 down from 2015 | 3,847 | 22% | $3,500 | ||
16Frontiers in ImmunologyOAFrontiers Media · Switzerland | 1.72Q1 | 7.01 2.74 up from 2015 | 2,445 | 100% | $3,801 | ||
17Journal of Leukocyte BiologyOxford University Press · United States | 1.71Q1 | 4.29 0.40 down from 2015 | 659 | 49% | $3,800 | ||
18The AAPS JournalSpringer Science+Business Media · United States | 1.69Q1 | 3.78 0.36 down from 2015 | 401 | 47% | $5,090 | ||
19International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.69Q1 | 3.73 0.44 up from 2015 | 72 | 100% | $1,000 | ||
20Clinical ImmunologyElsevier BV · Netherlands | 1.59Q1 | 4.07 0.05 down from 2015 | 494 | 32% | $4,400 | ||
21Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.59Q1 | 3.60 0.18 down from 2015 | 508 | 33% | — | ||
22Clinical and Developmental ImmunologyOAHindawi Publishing Corporation · United Kingdom | 1.55Q1 | —no 2015 value | 297 | — | $2,100 | ||
23Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.45Q1 | 3.63 0.26 up from 2015 | 694 | 92% | $3,816 | ||
24Molecular ImmunologyElsevier BV · Netherlands | 1.37Q2 | 3.72 0.22 up from 2015 | 768 | 26% | $3,340 | ||
25Immunology and Cell BiologyWiley · Australia | 1.37Q2 | 3.47 0.45 down from 2015 | 361 | 49% | $3,750 | ||
26International Reviews of ImmunologyTaylor & Francis · United States | 1.37Q2 | 2.86 1.28 down from 2015 | 124 | 35% | — | ||
27ImmunologyWiley · United Kingdom | 1.34Q2 | 3.31 0.22 down from 2015 | 537 | 88% | $5,330 | ||
28Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.34Q2 | 4.15 1.25 up from 2015 | 361 | 36% | $4,990 | ||
29Cellular and Molecular ImmunologySpringer Nature · China | 1.33Q2 | 3.86 0.57 up from 2015 | 325 | 100% | $5,190 | ||
30CytokineElsevier BV · United Kingdom | 1.31Q2 | 3.65 0.77 up from 2015 | 820 | 25% | $3,220 | ||
31BMC ImmunologyOABioMed Central · United Kingdom | 1.31Q2 | 3.24 0.49 up from 2015 | 201 | 100% | $3,090 | ||
32Immunity & AgeingOABioMed Central · United Kingdom | 1.30Q2 | 2.76 1.20 down from 2015 | 96 | 100% | $3,190 | ||
33European Journal of ImmunologyWiley · Germany | 1.30Q2 | 3.64 0.20 down from 2015 | 1,134 | 60% | $4,550 | ||
34BioDrugsAdis, Springer Healthcare · Switzerland | 1.29Q2 | 3.60 0.03 down from 2015 | 132 | 29% | $5,190 | ||
35Immunologic ResearchSpringer Science+Business Media · United States | 1.29Q2 | 2.85 0.64 down from 2015 | 367 | 25% | $2,890 | ||
36Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 1.23Q2 | 2.86 1.10 up from 2015 | 109 | 100% | $3,490 | ||
37ImmunobiologyOAElsevier BV · Germany | 1.21Q2 | 2.96 0.04 up from 2015 | 436 | 14% | $2,840 | ||
38Cellular ImmunologyElsevier BV · Netherlands | 1.20Q2 | 3.42 0.56 up from 2015 | 353 | 25% | $3,550 | ||
39Trends in ImmunologyElsevier BV · United Kingdom | 1.20Q2 | 10.41 0.78 down from 2015 | 255 | 52% | $7,030 | ||
40Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 1.15Q2 | 3.31 0.49 down from 2015 | 642 | 25% | $3,340 | ||
41Immunology LettersElsevier BV · Netherlands | 1.13Q2 | 3.02 0.13 up from 2015 | 492 | 21% | $3,290 | ||
42Inflammation ResearchSpringer Science+Business Media · Switzerland | 1.11Q2 | 2.79 0.15 down from 2015 | 321 | 14% | $4,790 | ||
43Critical Reviews in ImmunologyBegell House · United States | 1.09Q2 | 2.96 0.25 down from 2015 | 79 | 39% | — | ||
44Immune NetworkOASouth Korea | 1.09Q2 | 3.43 1.14 up from 2015 | 123 | 100% | — | ||
45Innate ImmunityOASAGE Publishing · United Kingdom | 1.05Q2 | 2.51 0.17 down from 2015 | 188 | 71% | $2,650 | ||
46American Journal of Reproductive ImmunologyWiley · United Kingdom | 1.05Q3 | 3.03 0.17 down from 2015 | 368 | 32% | $4,460 | ||
47Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.03Q3 | 2.32 0.19 down from 2015 | 104 | 8% | — | ||
48Genes and ImmunitySpringer Nature · United States | 1.02Q3 | 2.94 0.15 up from 2015 | 216 | 65% | $3,190 | ||
49Journal of Immunological MethodsElsevier BV · Netherlands | 0.95Q3 | 2.55 0.34 up from 2015 | 517 | 39% | $2,970 | ||
50Immunological ReviewsWiley · United States | 0.95Q3 | 10.48 0.64 down from 2015 | 330 | 55% | $5,000 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2016. Corpus-wide, 77.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
36 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2013–2015, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2016. Publication window: 2013–2015. How these summaries are calculated
- Ranked journals
- 90
- Window papers (baseline)
- 73,354 +8.5% from indicator year 2013
- Median OJR
- 1.05 +0.8% from indicator year 2013
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2013–2015 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.